Caoili E M, Korobkin M, Francis I R, Cohan R H, Dunnick N R
Department of Radiology, University of Michigan Medical Center, 1500 E. Medical Center Dr., Ann Arbor, MI 48109-9723, USA.
AJR Am J Roentgenol. 2000 Nov;175(5):1411-5. doi: 10.2214/ajr.175.5.1751411.
Although representing a minority of adrenal adenomas, the lipid-poor variety cannot be accurately identified on unenhanced CT or chemical shift MR imaging. We compared the delayed contrast-enhanced CT features of lipid-poor adenomas with those of lipid-rich adenomas and of adrenal nonadenomas to determine whether there were differences in the washout features between these groups of lesions.
Eighteen proven lipid-poor adenomas, 56 lipid-rich adenomas, and 40 adrenal nonadenomas underwent CT before, immediately after, and 15 min delay after IV contrast injection. Region-of-interest measurements were made of all adrenal lesions at the three time points. The degree of enhancement, enhancement washout, percentage enhancement washout, and relative percentage enhancement washout were calculated for each adrenal mass. Pooled data were analyzed statistically. Optimal threshold values for diagnosing adrenal adenomas were also determined.
The mean CT attenuation of lipid-poor adenomas was significantly higher than that of lipid-rich adenomas at all three phases but not significantly different from that of nonadenomas. The mean percentage enhancement washout on images obtained 15 min after administration of contrast material was similar for lipid-rich and lipid-poor adenomas but was significantly higher than that of nonadenomas. The mean relative percentage enhancement washout was significantly different among all three groups.
Lipid-poor adenomas cannot be differentiated from adrenal nonadenomas on the basis of a single mean attenuation value. However, lipid-poor adrenal adenomas show enhancement and enhancement washout features nearly identical to lipid-rich adenomas and can be distinguished from nonadenomas on the basis of a percentage washout threshold value of 60% and a relative percentage washout of 40%.
尽管乏脂性肾上腺腺瘤占肾上腺腺瘤的少数,但在平扫CT或化学位移磁共振成像上无法准确识别。我们比较了乏脂性腺瘤与富脂性腺瘤及肾上腺非腺瘤的延迟增强CT特征,以确定这些病变组之间的廓清特征是否存在差异。
18例经证实的乏脂性腺瘤、56例富脂性腺瘤和40例肾上腺非腺瘤在静脉注射造影剂前、注射后即刻及延迟15分钟后接受CT检查。在三个时间点对所有肾上腺病变进行感兴趣区测量。计算每个肾上腺肿块的强化程度、强化廓清、强化廓清百分比及相对强化廓清百分比。对汇总数据进行统计学分析。还确定了诊断肾上腺腺瘤的最佳阈值。
在所有三个阶段,乏脂性腺瘤的平均CT衰减均显著高于富脂性腺瘤,但与非腺瘤无显著差异。注射造影剂15分钟后图像上富脂性和乏脂性腺瘤的平均强化廓清百分比相似,但显著高于非腺瘤。所有三组之间的平均相对强化廓清百分比有显著差异。
基于单一的平均衰减值,乏脂性腺瘤无法与肾上腺非腺瘤区分开来。然而,乏脂性肾上腺腺瘤的强化和强化廓清特征与富脂性腺瘤几乎相同,基于60%的廓清阈值和40%的相对廓清百分比可与非腺瘤区分开来。